Long-term use of ticagrelor in patients with prior myocardial infarction.
| Author | |
|---|---|
| Abstract | :
The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with established efficacy after an acute coronary syndrome, in this context. |
| Year of Publication | :
2015
|
| Journal | :
The New England journal of medicine
|
| Volume | :
372
|
| Issue | :
19
|
| Number of Pages | :
1791-800
|
| Date Published | :
2015
|
| ISSN Number | :
0028-4793
|
| URL | :
https://www.nejm.org/doi/10.1056/NEJMoa1500857?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
|
| DOI | :
10.1056/NEJMoa1500857
|
| Short Title | :
N Engl J Med
|
| Download citation |